Additionally, our secondary aim is to evaluate patient outcomes—specifically, survival or mortality—corresponding to elevated protein and albumin levels in BAL and serum while considering factors such as patient age and the duration of mechanical ventilation for those affected by COVID-19 and Influenza type A ARDS. Here, ALB is linked to COVID-19.